Humatica’s new whitepaper on Buy & Build. Download now
Humatica’s new whitepaper on Buy & Build. Download now
Humatica’s new whitepaper on Buy & Build. Download now
By Humatica
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica Advisor to Riverside for AlterPharma
Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to announce four promotions in its London and Zurich offices. Paul Simpson…
Read more
We are proud to announce that following our record growth in 1H 2021, Humatica has moved to new and larger offices in central London. Andros…
Read more
Valentina Pozzobon, a Director and Board Member of Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, will take a full-time role…
Read more